Liu Y, Oroujeni M, Liao Y, Vorobyeva A, Bodenko V, Orlova A
Eur J Nucl Med Mol Imaging. 2024; 51(13):4038-4048.
PMID: 39008065
PMC: 11527907.
DOI: 10.1007/s00259-024-06840-5.
Wei Z, Li B, Wen X, Jakobsson V, Liu P, Chen X
Adv Sci (Weinh). 2024; 11(30):e2402361.
PMID: 38874523
PMC: 11321656.
DOI: 10.1002/advs.202402361.
Handula M, Beekman S, Konijnenberg M, Stuurman D, de Ridder C, Bruchertseifer F
EJNMMI Radiopharm Chem. 2023; 8(1):13.
PMID: 37389800
PMC: 10313624.
DOI: 10.1186/s41181-023-00197-0.
Chakraborty K, Mondal J, An J, Park J, Lee Y
Pharmaceutics. 2023; 15(3).
PMID: 36986832
PMC: 10054444.
DOI: 10.3390/pharmaceutics15030971.
Anderson P, Subbiah V, Trucco M
Front Med (Lausanne). 2022; 9:1030094.
PMID: 36457575
PMC: 9705365.
DOI: 10.3389/fmed.2022.1030094.
Small-scale dosimetry for alpha particle Am source cell irradiation and estimation of γ-H2AX foci distribution in prostate cancer cell line PC3.
Mellhammar E, Dahlbom M, Vilhelmsson-Timmermand O, Strand S
EJNMMI Phys. 2022; 9(1):46.
PMID: 35852717
PMC: 9296737.
DOI: 10.1186/s40658-022-00475-x.
Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology.
Pijeira M, Viltres H, Kozempel J, Sakmar M, Vlk M, Ilem-Ozdemir D
EJNMMI Radiopharm Chem. 2022; 7(1):8.
PMID: 35467307
PMC: 9038981.
DOI: 10.1186/s41181-022-00161-4.
A self-triggered radioligand therapy agent for fluorescence imaging of the treatment response in prostate cancer.
Xu H, Wang Y, Zhang J, Duan X, Zhang T, Cai X
Eur J Nucl Med Mol Imaging. 2022; 49(8):2693-2704.
PMID: 35235005
DOI: 10.1007/s00259-022-05743-7.
Brachytherapy Approach Using Lu Conjugated Gold Nanostars and Evaluation of Biodistribution, Tumor Retention, Dosimetry and Therapeutic Efficacy in Head and Neck Tumor Model.
Lin M, Hsieh H, Chen J, Chen C, Sheu N, Huang W
Pharmaceutics. 2021; 13(11).
PMID: 34834318
PMC: 8623985.
DOI: 10.3390/pharmaceutics13111903.
Combination of terbium-161 with somatostatin receptor antagonists-a potential paradigm shift for the treatment of neuroendocrine neoplasms.
Borgna F, Haller S, Monne Rodriguez J, Ginj M, Grundler P, Zeevaart J
Eur J Nucl Med Mol Imaging. 2021; 49(4):1113-1126.
PMID: 34625828
PMC: 8921065.
DOI: 10.1007/s00259-021-05564-0.
Next-Generation Molecular Imaging of Thyroid Cancer.
Jin Y, Liu B, Younis M, Huang G, Liu J, Cai W
Cancers (Basel). 2021; 13(13).
PMID: 34202358
PMC: 8268517.
DOI: 10.3390/cancers13133188.
The Challenge of Evaluating Response to Peptide Receptor Radionuclide Therapy in Gastroenteropancreatic Neuroendocrine Tumors: The Present and the Future.
Liberini V, Huellner M, Grimaldi S, Finessi M, Thuillier P, Muni A
Diagnostics (Basel). 2020; 10(12).
PMID: 33322819
PMC: 7763988.
DOI: 10.3390/diagnostics10121083.
Advancements in the use of Auger electrons in science and medicine during the period 2015-2019.
Howell R
Int J Radiat Biol. 2020; 99(1):2-27.
PMID: 33021416
PMC: 8062591.
DOI: 10.1080/09553002.2020.1831706.
Production of radiometals in liquid targets.
do Carmo S, Scott P, Alves F
EJNMMI Radiopharm Chem. 2020; 5(1):2.
PMID: 31925619
PMC: 6954154.
DOI: 10.1186/s41181-019-0088-x.
C-terminal-modified LY2510924: a versatile scaffold for targeting C-X-C chemokine receptor type 4.
Suzuki K, Ui T, Nagano A, Hino A, Arano Y
Sci Rep. 2019; 9(1):15284.
PMID: 31653903
PMC: 6814797.
DOI: 10.1038/s41598-019-51754-0.
Current outlook on radionuclide delivery systems: from design consideration to translation into clinics.
Peltek O, Muslimov A, Zyuzin M, Timin A
J Nanobiotechnology. 2019; 17(1):90.
PMID: 31434562
PMC: 6704557.
DOI: 10.1186/s12951-019-0524-9.
Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives.
Lepareur N, Lacoeuille F, Bouvry C, Hindre F, Garcion E, Cherel M
Front Med (Lausanne). 2019; 6:132.
PMID: 31259173
PMC: 6587137.
DOI: 10.3389/fmed.2019.00132.
Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine.
Man F, Gawne P, T M de Rosales R
Adv Drug Deliv Rev. 2019; 143:134-160.
PMID: 31170428
PMC: 6866902.
DOI: 10.1016/j.addr.2019.05.012.
Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008⁻2018).
Uccelli L, Martini P, Cittanti C, Carnevale A, Missiroli L, Giganti M
Molecules. 2019; 24(3).
PMID: 30759753
PMC: 6385165.
DOI: 10.3390/molecules24030640.
Early Evaluation of Copper Radioisotope Production at ISOLPHARM.
Borgna F, Ballan M, Favaretto C, Verona M, Tosato M, Caeran M
Molecules. 2018; 23(10).
PMID: 30249975
PMC: 6222311.
DOI: 10.3390/molecules23102437.
